Pharmacological Potential of Lathyrane-Type Diterpenoids from Phytochemical Sources

• Main Authors: Fátima Vela (Author), Abdellah Ezzanad (Author), Alan Christy Hunter (Author), Antonio José Macías-Sánchez (Author), Rosario Hernández-Galán (Author)
• Format: Book
• Published: MDPI AG, 2022-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.
• Notes: 10.3390/ph15070780; 1424-8247
• Keywords: lathyrane; biological activity; diterpene; <i>Euphorbia</i>; Medicine; R; Pharmacy and materia medica; RS1-441
• Source: Pharmaceuticals, Vol 15, Iss 7, p 780 (2022)

Lathyrane diterpenoids are one of the primary types of secondary metabolites present in the genus <i>Euphorbia</i> and one of the largest groups of diterpenes. They are characterized by having a highly oxygenated tricyclic system of 5, 11 and 3 members. These natural products and some synthetic derivatives have shown numerous interesting biological activities with clinical potential against various diseases, such as cytotoxic activity against cancer cell lines, multi-drug resistance reversal, antiviral properties, anti-inflammatory activity and their capability to induce proliferation or differentiation into neurons of neural progenitor cells. The structure of the lathyrane skeleton could be considered privileged because its framework is able to direct functional groups in a well-defined space. The favorable arrangement of these makes interaction possible with more than one target. This review aims to highlight the evidence of lathyranes as privileged structures in medicinal chemistry. Chemical structures of bioactive compounds, the evaluation of biological properties of natural and semisynthetic derivatives, and the exploration of the mechanisms of action as well as target identification and some aspects of their targeted delivery are discussed.